Replies to post #47083 on Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

Unfortunate, but it shows perhaps shortcomings in the science is partly to blame for the sharholder value erosion.

[smasse]

Is it true anal trial is a bust?..only 1 of 30 got partial..after supposed
10 out of 10 responded on first trial???..if so..THIS alone is reason enough to look long and hard about getting out..i am in for science...when i see it isn't working..head for the door. Can anyone verify this terrible result?

[Simple Steve]

Wait a minute. Something is not right. I never saw any AXAL anal results. 1 partial responder out of 30? ADXS is dropping Fawcett anal drug? I never heard that. You have any references? CC didn't seem to talk about AXAL anal, but it talked about AXAL cervical. If true, that ADXS has dropped AXAL anal due to terrible trial results, and they also dropped HER-2, then this may be proof the science is a failure. But I want to see evidence of their failures. Is SDXS hiding these failures?

[BarrellofHay]

So ADXS chose not to initiate stage 2 of the anal study. Questions/comments?? What do we have left in terms of good results from past studies that we can sink our teeth into? Just the AXAL cervical data?? Is that all the company has to show for itself after hundreds and hundreds of millions spent??